Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Liver cirrhosis and

HBV infection remains a major worldwide public health problem. The World Health Organization estimates that there are still 350 million chronic carriers of the vims, who are at risk of developing chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. The success of IFN-a treatment - mainly performed as combined treatment with adenine-arabinoside - has been measured by the normalization of liver enzymes, loss of HBe antigen and of detectable viral DNA in the serum of patients. It has been estimated from several clinical trials that as many as 40% of treated HBV patients would respond to therapy with IFN-a or combined treatment with nucleoside analogues and IFN-a. [Pg.645]

Helps to improve liver cirrhosis and helps in liver detoxification. [Pg.356]

Tocotrienols, gamma Oryzanol Phosphatidyl chohne Antioxidants Controls liver cirrhosis and helps in effective liver detoxification (Bruni, 1988). Protectant against hver damage (Kidd, 1996). Antioxidant enzymes prevent hpid peroxidation and helps protecting the liver cells from damage. [Pg.357]

Johansson, V., Johnsson, F., Joelsson, B., Beiglund, M. and Akesson, B. (1986). Selenium status in patients with liver cirrhosis and alcoholism. Br. J. Nutr. 55, 227-233. [Pg.165]

ALAD, an enzyme occurring early in the heme pathway, is also considered a sensitive indicator of lead effect (Hemberg et al. 1970 Morris et al. 1988 Somashekaraiah et al. 1990 Tola et al. 1973). Because there is no well-defined blood lead threshold at which inhibition of ALAD does not occur, it allows measurement of the effect on the general population at environmental lead levels and does not require high exposure levels as with occupational workers (Hemberg et al. 1970). However, ALAD activity may also be decreased with other diseases or conditions such as porphyria, liver cirrhosis, and alcoholism (Somashekaraiah et al. 1990). [Pg.320]

The potent antidiuretic hormone AVP orchestrates the regulation of free water absorption, body fluid osmolality, cell contraction, blood volume, and blood pressure through stimulation of three G-protein-coupled receptor subtypes Vi-vascular types a and b, V2-renal, and V3-pituitary. Increased AVP secretion is the trademark of several pathophysiological disorders, including heart failure, impaired renal function, liver cirrhosis, and SIADH. As a consequence, these patients experience excess water retention or inadequate free-water excretion, which results in the dilution of sodium concentrations, frequently manifesting as clinical hyponatremia (serum sodium concentration <135mmol/L). This electrolyte imbalance increases mortality rates by 60-fold. Selective antagonism of the AVP V2 receptor promotes water... [Pg.528]

Chronic forms of hepatitis (in particular B, C and D) can result in liver cirrhosis and/or hepatocellular carcinoma. This occurs in up to 20 per cent of chronic hepatitis B sufferers and in up to 30 per cent of chronic hepatitis C sufferers. The scale of human suffering caused by hepatitis on a worldwide basis is enormous. Approximately 5 per cent of the global population suffer from chronic hepatitis B. An estimated 50 million new infections occur each year. Over 1.5 million of the 300 million carriers worldwide die annually from liver cirrhosis and hepatocellular carcinoma. [Pg.229]

FIGURE 34-3 Positron emission tomography using 13NH3 showing increased brain ammonia uptake in a patient with liver cirrhosis and mild hepatic encephalopathy. CMRA, cerebral metabolic ratio for ammonia HE, hepatic encephalopathy PS, permeability/surface area product. (With permission from reference [9].)... [Pg.598]

Wilson s disease is an autosomal recessive disorder characterized by the accumulation of copper in liver and brain [21]. Hepatic involvement may result in liver cirrhosis and hepatic cancer. The deposition of copper in the basal ganglia results in a variety of movement disorders, including... [Pg.773]

Postmortem examination of 17 lambs that died suddenly showed brain histopathology, particularly in white matter of midbrain, pons, and cerebellum. Severe liver cirrhosis and necrosis of kidney tubules. Liver copper elevated at 3225 to 4325 mg/kg DW... [Pg.205]

Balikov et al. (B2), using the method which they devised especially for the determination of urinary peptides, demonstrated a marked increase of these compounds in urine of patients suffering from bums. Using the same method, Samecka-Keller observed a considerable rise in the amount of urinary peptides in liver cirrhosis and leukemia (SI). [Pg.137]

The nitrogen content of this mixture amounted in the case of normal urine to 0.68-1.27% of the total nitrogen, whereas the peptides precipitated under these circumstances constituted 16.1-20.9% of all substances appearing in urine and giving the biuret reaction. The peptide mixtures obtained in identical conditions from six samples of pathological urine (liver cirrhosis and leukemia) exhibited marked differences in the nitrogen and peptide content as compared with those isolated from normal urine. [Pg.140]

This point of view overlooks the fact that every well and normal individual is potentially an ill individual, and the roots of disease may be present in his make-up years before there is any overt disease. A dozen young men used as normal controls may each have metabolic peculiarities that point toward a different metabolic derangement gout, multiple sclerosis, diabetes, anemia, atherosclerosis, hypertension, nephrosis, hypothyroidism, rheumatoid arthritis, rheumatic heart disease, liver cirrhosis, and myasthenia gravis, for example, and yet at the time of their use as controls these young men may show no symptoms of the disease which is to appear later in life. It seems far from safe to assume that because an individual on clinical examination seems well, all of his blood values, for example, are normal and meaningless so far as disease susceptibilities are concerned. [Pg.238]

Despite the positive effects of optimal levels of copper, deleterious effects may occur if a threshold level is exceeded. Wilson s disease (hepatolenticularic degeneration) is one of the diseases linked to the excess of copper in the body. It results from a dysfunction of the copper transmission process, which occurs due to a lack of suitable enzyme to catalyze the process of copper deletion from detached bonds with albumins and binding to ceruloplasma. The condition leads to neuron degradation, liver cirrhosis, and occurrence of colorful rings on the cornea (DiDonato and Sarkar, 1997). [Pg.247]

Dinretics are widely used in medicine for very diverse pathologies, primarily for relieving edema, treating hypertension, cardiac insufficiency, hypercalcinuria, glaucoma, and a few forms of epilepsy, liver cirrhosis, and nephrosis. [Pg.277]

Bendroflnmethiazide may be nsed for the same indications as the aforementioned drugs however, it is primarily used as an adjnvant agent for reheving edema associated with cardiac insnfficiency, liver cirrhosis, and edema cansed by taking corticosteroids. Synonyms of this drng are sinesalin, docidrazine, tensionorm, aprinox, naturetin, and others. [Pg.282]

Adams et al. 1952). After 5 weeks of an exposure sufficient to induce liver cirrhosis and altered vitamin A concentration in several tissues of the rat, wet lung weight was increased by 10%, but lung vitamin A content remained normal (Chapman et al. 1992). As it appears that lung injury is secondary to renal injury, then the absence of lung effects in animals may be because animals are also less susceptible to the renal injury produced by carbon tetrachloride than are humans. [Pg.30]

Unlabeled Uses Treatment of edema associated with CHF, liver cirrhosis, and nephrotic syndrome treatment of hypertension reduces lithium-induced polyuria, slows pulmonary function reduction in cystic fibrosis... [Pg.51]

Type IV/Andersen failure to thrive, hypotonia, hepatomegaly, splenomegaly, progressive liver cirrhosis and failure (death usually before fifth year) some without progression Type V/McArdle exercise intolerance, muscle cramps, myoglobinuria on strenuous exercise, increased creatine kinase (predominantly in male)... [Pg.247]

Liver disease is the most common medical complication of alcohol abuse an estimated 15-30% of chronic heavy drinkers eventually develop severe liver disease. Alcoholic fatty liver, a reversible condition, may progress to alcoholic hepatitis and finally to cirrhosis and liver failure. In the United States, chronic alcohol abuse is the leading cause of liver cirrhosis and of the need for liver transplantation. The risk of developing liver disease is related both to the average amount of daily consumption and to the duration of alcohol abuse. Women appear to be more susceptible to alcohol hepatotoxicity than men. Concurrent infection with hepatitis or C virus increases the risk of severe liver disease. [Pg.495]

These substances can break up or drive out congealed blood. They are used to treat a solid mass that is formed by congealed blood, phlegm, dampness, cold or heat and toxin. Some substances in this group are poisonous. Their poisonous nature can effectively conquer the pathogenic substances in the body. They are only used in formulas that treat very severe conditions, such as hepatosplenomegaly, liver cirrhosis and cancer. [Pg.276]

Carbon tetrachloride is a hepato toxic solvent, which causes centrilobular necrosis and fatty liver, liver cirrhosis, and tumors and kidney damage after chronic exposure. It is metabolized... [Pg.393]

Frezza, E.E., Gerunda, G.E., Farinati, F., DeMaria, N., Galligioni, A., Plebani, F., Giacomin, A Van Thiel, D.H. (1994) CCl4-induced liver cirrhosis and hepatocellular carcinoma in rats relation to plasma zinc, copper and estradiol levels. Hepato-Gastroenterology, 41, 367-369... [Pg.426]

Erythropoietic porphyrias The erythropoietic porphyrias (congenital erythropoietic porphyria and erythropoietic proto porphyria) are characterized by skin rashes and blisters lhat appear in early childhood. The diseases are complicated by cholestatic liver cirrhosis and progressive hepatic failure. [Pg.278]

However, in a double-blind study in 100 patients with compensated non-alcoholic liver cirrhosis and type 2 diabetes, acarbose for 28 weeks did not alter liver function (64). The number of hypoglycemic episodes was reduced. [Pg.363]

Mannucci PM, Vicente V, Vianello L, Cattaneo M, Alberca I, Coccato MP, Faioni E, Mari D. Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time. Blood 1986 67(4) 1148-53. [Pg.484]

Infection by human hepatitis B or C virus is a major risk factor for the development of liver cirrhosis and hepatocellular carcinoma (HCC) (Brechot, et al., 2000, Colombo, et al., 2003). Although they act via different mechanisms, both viruses directly influence the control of Ca2+ homeostasis in human hepatocytes. One of the proteins encoded by the HBV genome, the hepatitis virus X protein... [Pg.412]

Administration of separate isomeric forms of BHC (a, 6) produced liver tumors and lung metastases in mice, whether bred for a low or high incidence of spontaneous tumors (ref. 100). Effects of BHC reported on exposed humans Include liver cirrhosis and chronic hepatitis in 8 workers also cases of aplastic anemia and leukemia (ref. 100, p. 157). Animal studies to date focused primarily on the reproductive effects of lindane are both insufficient and inconclusive. Earl et al. reported fetotoxic effects (stillbirths, perinatal deaths) in beagles (ref. [Pg.328]

Pantoprazole is subject to low first-pass hepatic extraction, as reflected in an estimated absolute oral bioavailability of 77%. On repeated oral administration, the pharmacokinetics of pantoprazole (20 and 40 mg once daily) are similar to those after single dose administration [1,18]. The absolute bioavailability was 70% in patients with severe liver cirrhosis, and more than 90% in healthy elderly subjects [18]. [Pg.254]

During the 1970s and 1980s, the synthetic aldosterone antagonist spironolactone (Fig. 17.3) [5] was used extensively (among others) as a diuretic agent for the treatment of edema, liver cirrhosis and certain cardiac diseases. [Pg.396]

In this chapter Case studies levels 1-3 explore the management of a patient with alcoholic liver disease. The patient has alcoholic liver cirrhosis and first presents with alcohol withdrawal (Case study level 1), then the patient s risk of bleeding and treatment for the maintenance of alcohol abstinence are considered (Case study level 2). The patient then goes on to develop encephalopathy (Case study level 3). Case studies levels Ma and Mb consider two patients one presents with TB and the other liver failure. [Pg.338]


See other pages where Liver cirrhosis and is mentioned: [Pg.8]    [Pg.530]    [Pg.113]    [Pg.402]    [Pg.619]    [Pg.763]    [Pg.314]    [Pg.205]    [Pg.276]    [Pg.277]    [Pg.361]    [Pg.1205]    [Pg.445]    [Pg.245]    [Pg.194]    [Pg.226]    [Pg.245]   
See also in sourсe #XX -- [ Pg.270 ]




SEARCH



Liver Cirrhosis Causes and Therapy

Liver Disease and Cirrhosis

Liver cirrhosis

© 2024 chempedia.info